New Product Brand Planning


Client Type A mid-size biopharma company
Function Enhancement of position in the marketplace by leading the formation of a mid-size biopharma company's R&D portfolio strategy for its gene therapy division.
Challenge No unified launch roadmap
Impact Single coordinated launch plan

Challenge

Client lacked a unified launch roadmap for a first‑in‑class asset in a new treatment area, risking fragmented execution and missed uptake windows.

Approach

Scimitar facilitated cross‑functional workshops and conducted ~30 physician interviews to align functions, identify areas of synergy, and locate strategic and tactical gaps. Outputs informed development of a consolidated launch plan.

Impact

Scimitar delivered a single Launch Plan with situation analysis, brand plan, and functional tactical plans, enabling coordinated launch execution and faster internal decision‑making.

Talk through a similar challenge.

Facing a version of this problem? Bring it to a conversation and we will walk through what it would take to make the change real.